Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acid, Essential Amino
2. Acids, Essential Amino
3. Amino Acid, Essential
4. Amino Acids, Essential
5. Essential Amino Acid
1. Amino Acids, Essential
2. Amino Acids, Essential-
3. E500000000
Molecular Weight | 1163.4 g/mol |
---|---|
Molecular Formula | C52H94N10O17S |
Hydrogen Bond Donor Count | 19 |
Hydrogen Bond Acceptor Count | 27 |
Rotatable Bond Count | 25 |
Exact Mass | 1162.65191274 g/mol |
Monoisotopic Mass | 1162.65191274 g/mol |
Topological Polar Surface Area | 594 Ų |
Heavy Atom Count | 80 |
Formal Charge | 0 |
Complexity | 988 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 8 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3131
Submission : 1978-02-27
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-06-03
Pay. Date : 2020-05-21
DMF Number : 32088
Submission : 2017-09-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27952
Submission : 2014-01-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15386
Submission : 2001-04-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2631
Submission : 1976-03-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6062
Submission : 1985-09-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5896
Submission : 1985-06-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1990
Submission : 1972-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4194
Submission : 1981-05-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4202
Submission : 1981-05-29
Status : Inactive
Type : II
Isoleucine, Limeira Amino Acid Site
Certificate Number : R1-CEP 2009-100 - Rev 00
Status : Valid
Issue Date : 2014-12-16
Type : Chemical
Substance Number : 770
Details:
NuGenea is a nutraceutical formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation, which is a causative factor in illnesses such as cancer, diabetes, COPD and heart disease.
Lead Product(s): Amino Acids Mixture
Therapeutic Area: Immunology Brand Name: NuGenea
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 25, 2023
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Immunology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
Details : NuGenea is a nutraceutical formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation, which is a causative factor in illnesses such as cancer, diabetes, COPD and heart disease.
Brand Name : NuGenea
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 25, 2023
Details:
PKU GOLIKE® - a next generation medical phenylalanine-free food product engineered with the patent protected, pharmaceutical grade Physiomimic™ technology for the dietary management of phenylketonuria (PKU).
Lead Product(s): Amino Acids Mixture
Therapeutic Area: Genetic Disease Brand Name: PKU GOLIKE
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 10, 2022
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Relief Announces U.S. Launch of PKU GOLIKE
Details : PKU GOLIKE® - a next generation medical phenylalanine-free food product engineered with the patent protected, pharmaceutical grade Physiomimic™ technology for the dietary management of phenylketonuria (PKU).
Brand Name : PKU GOLIKE
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 10, 2022
Details:
Acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure foundation for future product launches.
Lead Product(s): Amino Acids Mixture,Minerals,Vitamins
Therapeutic Area: Genetic Disease Brand Name: PKU Golike
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Relief Therapeutics
Deal Size: $72.2 million Upfront Cash: $23.3 million
Deal Type: Acquisition June 29, 2021
Lead Product(s) : Amino Acids Mixture,Minerals,Vitamins
Therapeutic Area : Genetic Disease
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Relief Therapeutics
Deal Size : $72.2 million
Deal Type : Acquisition
Details : Acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure foundation for future product launches.
Brand Name : PKU Golike
Molecule Type : Small molecule
Upfront Cash : $23.3 million
June 29, 2021
DRUG PRODUCT COMPOSITIONS
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Amino Acids Mixture manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amino Acids Mixture, including repackagers and relabelers. The FDA regulates Amino Acids Mixture manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amino Acids Mixture API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amino Acids Mixture supplier is an individual or a company that provides Amino Acids Mixture active pharmaceutical ingredient (API) or Amino Acids Mixture finished formulations upon request. The Amino Acids Mixture suppliers may include Amino Acids Mixture API manufacturers, exporters, distributors and traders.
click here to find a list of Amino Acids Mixture suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amino Acids Mixture DMF (Drug Master File) is a document detailing the whole manufacturing process of Amino Acids Mixture active pharmaceutical ingredient (API) in detail. Different forms of Amino Acids Mixture DMFs exist exist since differing nations have different regulations, such as Amino Acids Mixture USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amino Acids Mixture DMF submitted to regulatory agencies in the US is known as a USDMF. Amino Acids Mixture USDMF includes data on Amino Acids Mixture's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amino Acids Mixture USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amino Acids Mixture suppliers with USDMF on PharmaCompass.
A Amino Acids Mixture CEP of the European Pharmacopoeia monograph is often referred to as a Amino Acids Mixture Certificate of Suitability (COS). The purpose of a Amino Acids Mixture CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Amino Acids Mixture EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Amino Acids Mixture to their clients by showing that a Amino Acids Mixture CEP has been issued for it. The manufacturer submits a Amino Acids Mixture CEP (COS) as part of the market authorization procedure, and it takes on the role of a Amino Acids Mixture CEP holder for the record. Additionally, the data presented in the Amino Acids Mixture CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Amino Acids Mixture DMF.
A Amino Acids Mixture CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Amino Acids Mixture CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Amino Acids Mixture suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amino Acids Mixture as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amino Acids Mixture API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amino Acids Mixture as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amino Acids Mixture and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amino Acids Mixture NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amino Acids Mixture suppliers with NDC on PharmaCompass.
Amino Acids Mixture Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amino Acids Mixture GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amino Acids Mixture GMP manufacturer or Amino Acids Mixture GMP API supplier for your needs.
A Amino Acids Mixture CoA (Certificate of Analysis) is a formal document that attests to Amino Acids Mixture's compliance with Amino Acids Mixture specifications and serves as a tool for batch-level quality control.
Amino Acids Mixture CoA mostly includes findings from lab analyses of a specific batch. For each Amino Acids Mixture CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amino Acids Mixture may be tested according to a variety of international standards, such as European Pharmacopoeia (Amino Acids Mixture EP), Amino Acids Mixture JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amino Acids Mixture USP).
LOOKING FOR A SUPPLIER?